AU2001249251A1 - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides

Info

Publication number
AU2001249251A1
AU2001249251A1 AU2001249251A AU4925101A AU2001249251A1 AU 2001249251 A1 AU2001249251 A1 AU 2001249251A1 AU 2001249251 A AU2001249251 A AU 2001249251A AU 4925101 A AU4925101 A AU 4925101A AU 2001249251 A1 AU2001249251 A1 AU 2001249251A1
Authority
AU
Australia
Prior art keywords
polypeptides
nucleic acids
novel nucleic
novel
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001249251A
Other languages
English (en)
Inventor
Rodoje T. Drmanac
Chenghua Liu
Y. Tom Tang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyseq Inc
Original Assignee
Hyseq Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc filed Critical Hyseq Inc
Publication of AU2001249251A1 publication Critical patent/AU2001249251A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001249251A 2000-03-31 2001-03-30 Novel nucleic acids and polypeptides Abandoned AU2001249251A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US54021700A 2000-03-31 2000-03-31
US09/540,217 2000-03-31
US64916700A 2000-08-23 2000-08-23
US09/649,167 2000-08-23
PCT/US2001/008631 WO2001075067A2 (fr) 2000-03-31 2001-03-30 Nouveaux acides nucleiques et polypeptides

Publications (1)

Publication Number Publication Date
AU2001249251A1 true AU2001249251A1 (en) 2001-10-15

Family

ID=27066367

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001249251A Abandoned AU2001249251A1 (en) 2000-03-31 2001-03-30 Novel nucleic acids and polypeptides

Country Status (3)

Country Link
US (7) US6436703B1 (fr)
AU (1) AU2001249251A1 (fr)
WO (1) WO2001075067A2 (fr)

Families Citing this family (566)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972697A (en) 1995-11-13 1999-10-26 The Salk Institute For Biological Studies NIMA interacting proteins
US7125677B2 (en) 1995-11-13 2006-10-24 The Salk Institute For Biological Studies NIMA interacting proteins
US20050163818A1 (en) * 1996-11-05 2005-07-28 Hsing-Wen Sung Drug-eluting device chemically treated with genipin
US7351421B2 (en) * 1996-11-05 2008-04-01 Hsing-Wen Sung Drug-eluting stent having collagen drug carrier chemically treated with genipin
ES2308800T3 (es) 1997-01-08 2008-12-01 Invitrogen Corporation Metodos para la produccion de proteinas.
US20030082540A1 (en) * 1997-09-17 2003-05-01 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7417126B2 (en) * 1997-10-17 2008-08-26 Genentech, Inc. PRO246 antibodies
WO1999042582A1 (fr) * 1998-02-19 1999-08-26 Smithkline Beecham Corporation Ammaid, un recepteur couple a une proteine g
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US6960570B2 (en) 1998-03-18 2005-11-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7258860B2 (en) 1998-03-18 2007-08-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6696247B2 (en) 1998-03-18 2004-02-24 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6833438B1 (en) 1999-06-01 2004-12-21 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
PT1086223E (pt) 1998-06-01 2009-11-03 Agensys Inc Novos antigénios transmembranares em serpentina expressos em cancros humanos e suas utilizações
US20030149531A1 (en) 2000-12-06 2003-08-07 Hubert Rene S. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US20030049700A1 (en) * 2000-09-25 2003-03-13 Rosana Kapeller-Libermann 22108 and 47916, novel human thioredoxin family members and uses thereof
US7339033B2 (en) * 1998-06-26 2008-03-04 Genentech, Inc. Pro1481
US7091315B1 (en) 1998-07-15 2006-08-15 Human Genome Sciences, Inc. Protein HDPBQ71
US20070072248A1 (en) * 1998-10-13 2007-03-29 Arena Pharmaceuticals, Inc. Constitutively activated human G protein coupled receptors
US20030229216A1 (en) * 1998-10-13 2003-12-11 Ruoping Chen Constitutively activated human G protein coupled receptors
US20080213778A1 (en) 1998-12-30 2008-09-04 Millennium Pharmaceuticals, Inc. Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
US20030190669A1 (en) 1998-12-30 2003-10-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7041474B2 (en) 1998-12-30 2006-05-09 Millennium Pharmaceuticals, Inc. Nucleic acid encoding human tango 509
US7238790B2 (en) * 1999-01-12 2007-07-03 Genentech, Inc. PRO1313 polypeptides
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US6649342B1 (en) 1999-03-15 2003-11-18 Eos Biotechnology, Inc. Methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
US6943235B1 (en) 1999-04-12 2005-09-13 Agensys, Inc. Transmembrane protein expressed in prostate cancer
EP1268506A4 (fr) * 1999-07-30 2004-07-28 Millennium Pharm Inc Proteine secretees et leurs applications
EP1218411A4 (fr) * 1999-09-20 2004-09-01 Millennium Pharm Inc Proteines secretees et leurs utilisations
US20030228640A1 (en) * 1999-10-15 2003-12-11 University Of Pittsburgh Nuclear matrix proteins, polynucleotide sequences encoding them, and their use
WO2001040249A1 (fr) * 1999-12-01 2001-06-07 Human Genome Sciences, Inc. Quatre polynucleotides contenant un domaine noyau de disulfure (fdcd), polypeptides, et anticorps
CA2494705A1 (fr) * 1999-12-01 2001-06-07 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides
WO2003048326A2 (fr) * 2001-12-03 2003-06-12 Nuvelo, Inc. Procedes et matieres associes a de nouveaux polypeptides et polynucleotides
IL150873A0 (en) 2000-01-26 2003-02-12 Agensys Inc 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
WO2001057214A2 (fr) * 2000-02-03 2001-08-09 Lexicon Genetics Incorporated Nouvelles proteines transporteuses humaines et polynucleotides codant pour ces proteines
US6806254B2 (en) * 2000-02-03 2004-10-19 Nuvelo, Inc. Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
JP2004500082A (ja) * 2000-02-03 2004-01-08 ハイセック，インコーポレーテッド ニューロトリミン様ポリペプチドおよびポリヌクレオチドに関する方法と材料
US7700341B2 (en) 2000-02-03 2010-04-20 Dendreon Corporation Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
WO2001070969A2 (fr) * 2000-03-22 2001-09-27 Bayer Aktiengesellschaft Regulation du recepteur humain couple a la proteine g semblable a latrophiline
AU2001252233A1 (en) * 2000-03-27 2001-10-15 Bayer Aktiengesellschaft Human tyrosine phosphatase-like enzymes
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
JP2004500120A (ja) * 2000-03-31 2004-01-08 ハイセク　インコーポレイテッド インスリン様増殖因子結合タンパク質様ポリペプチドおよびポリヌクレオチドに関する方法と材料
WO2001075093A1 (fr) * 2000-03-31 2001-10-11 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
GB0008305D0 (en) * 2000-04-06 2000-05-24 Neutec Pharma Plc Treatment of fungal infections
US7183397B2 (en) * 2000-04-19 2007-02-27 Merck Patent Gmbh NK-2 homeobox transcription factor
US7371388B1 (en) 2000-05-04 2008-05-13 Human Genome Sciences, Inc. Treatment of Sjogren's syndrome by administration of TR18 polypeptides
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001094390A2 (fr) 2000-06-06 2001-12-13 Millennium Pharmaceuticals, Inc. 52906, 33408, et 12189, nouveaux elements de la famille de canaux de potassium et leurs utilisations
EP1290215A2 (fr) * 2000-06-07 2003-03-12 Cyclacel Limited Proceder pour observer l'activite d'une enzyme
AU8573401A (en) * 2000-06-12 2001-12-24 Bayer Aktiengesellschaft Regulation of human epithin-like serine protease
EP1293510A4 (fr) * 2000-06-22 2005-02-09 Takeda Pharmaceutical Nouveau polypeptide et son adn
DK1297006T3 (da) 2000-06-23 2006-05-22 Bayer Healthcare Ag Regulering af human prostasin-lignende serinprotease
AU2001272493A1 (en) * 2000-06-26 2002-01-08 Merck Patent G.M.B.H Receptor for phosphoinositides-1 associated scaffold protein
DK1325115T3 (en) * 2000-06-26 2016-11-21 Zymogenetics Inc CYTOKINRECEPTOR ZCYTOR17
AU2001271618B8 (en) * 2000-06-28 2006-04-27 Amgen, Inc. B7-Like molecules and uses thereof
US7355023B2 (en) * 2000-06-29 2008-04-08 Duke University Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same
US20020064821A1 (en) * 2000-07-05 2002-05-30 Merkulov Gennady V. Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
AU2001281967A1 (en) * 2000-07-18 2002-01-30 Bayer Aktiengesellschaft Regulation of human desc1-like serine protease
WO2002008392A2 (fr) * 2000-07-25 2002-01-31 Bayer Aktiengesellschaft Regulation de la serine protease humaine semblable a matriptase
AU2001283062A1 (en) 2000-08-02 2002-02-13 The Johns Hopkins University Endothelial cell expression patterns
WO2002012330A2 (fr) * 2000-08-04 2002-02-14 Zymogenetics, Inc. Zzp1, proteine humaine secretee
WO2002012469A2 (fr) * 2000-08-09 2002-02-14 Millennium Pharmaceuticals, Inc. 27803, un nouveau membre de la famille adenylate kinase humaine et ses utilisations
ATE397015T1 (de) * 2000-08-21 2008-06-15 Organon Nv Coaster, ein humaner coaktivator von steroidrezeptoren
DE60120440T2 (de) * 2000-09-22 2007-01-04 Kyowa Hakko Kogyo Co., Ltd. Zellkernlokalisierendes protein für beta-catenin
AU2002210514A1 (en) * 2000-09-27 2002-04-08 Bayer Aktiengesellschaft Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
EP1349930A2 (fr) * 2000-10-05 2003-10-08 Curagen Corporation Polypeptides humains, acides nucleiques codant ces deuniers et leurs methodes d'utilisation
AU2001293863A1 (en) * 2000-10-05 2002-04-15 Bayer Aktiengesellschaft Regulation of human sodium-dependent monoamine transporter
AU1153902A (en) * 2000-10-06 2002-04-15 Univ Yale Nogo receptor homologs
US20030190715A1 (en) * 2000-10-12 2003-10-09 Grosse William M. Novel proteins and nucleic acids encoding same
AU2002224427A1 (en) * 2000-10-18 2002-04-29 Zymogenetics Inc. Human cyclic nucleotide binding protein
AU2002210403A1 (en) 2000-10-20 2002-04-29 Como Biotech Aps Pregnancy-associated plasma protein-a2 (papp-a2)
US20030068624A1 (en) * 2000-10-26 2003-04-10 Recipon Herve E. Compositions and methods relating to lung specific genes and proteins
JP2004528823A (ja) 2000-10-31 2004-09-24 ディアデクサス インコーポレーテッド 大腸特異的遺伝子およびタンパク質に関する組成物および方法
WO2002050278A2 (fr) * 2000-11-15 2002-06-27 Lexicon Genetics Incorporated Nouvelles proteines humaines secretees et polynucleotides les codant
DE60142646D1 (en) 2000-11-22 2010-09-02 Univ Maryland Fusionprotein
AU2002233201A1 (en) * 2000-11-27 2002-06-03 Bayer Aktiengesellschaft Regulation of human tyrosine phosphatase
US20020081653A1 (en) * 2000-11-28 2002-06-27 Chunhua Yan Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002046477A2 (fr) * 2000-12-07 2002-06-13 Chiron Corporation Retrovirus endogenes regules positivement dans le cancer de la prostate
JP2004517622A (ja) * 2000-12-11 2004-06-17 レキシコン・ジェネティクス・インコーポレーテッド 新規ヒトキナーゼ及び該キナーゼをコードするポリヌクレオチド
DE10061931A1 (de) * 2000-12-13 2001-09-06 Marianne Kroepelin Nukleinsäuresequenz "M73791" als humanes Gen und deren Derivate, sowie deren Transkriptions- und Translationsprodukte, zur kommerziellen Verwendung in Diagnostik und Therapie
WO2002057460A2 (fr) 2000-12-20 2002-07-25 Bristol-Myers Squibb Company Polynucleotides codant pour de nouvelles phosphatases humaines
US6949363B2 (en) 2000-12-22 2005-09-27 Brilstol-Myers Squibb Polynucleotides encoding novel human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1
EP1357186A4 (fr) * 2000-12-28 2005-01-26 Takeda Pharmaceutical Nouvelles proteines et adn correspondant
WO2002053748A1 (fr) * 2001-01-02 2002-07-11 Bayer Aktiengesellschaft Regulation de 3-$g(b)-hydroxysteroide deshydrogenase-isomerase
US6605710B2 (en) * 2001-01-11 2003-08-12 Board Of Trustees Of Michigan State University Gene whose expression promotes differentiation of myeloid progenitor cells into neutrophils and/or monocytes/macrophages
GB0100750D0 (en) * 2001-01-11 2001-02-21 Inpharmatica Ltd Novel proteins
CA2434677A1 (fr) * 2001-01-12 2002-10-10 Incyte Genomics, Inc. Molecules utilisees a des fins diagnostiques et therapeutiques
WO2002055664A2 (fr) * 2001-01-12 2002-07-18 Exelixis, Inc. Modulation de la signalisation du recepteur de l'insuline
GB2375110A (en) * 2001-01-30 2002-11-06 Aeomica Inc Human LCCL_domain containing peptides
US7041643B2 (en) 2001-01-31 2006-05-09 Millennium Pharmaceuticals, Inc. Molecules of the PYRIN/NBS/LRR protein family and uses thereof
EP1515981A4 (fr) * 2001-01-31 2005-03-23 Millennium Pharm Inc Nouvelles molecules de la famille des proteines pyrin/nbs/lrr et leurs utilisations
AU2002229440A1 (en) * 2001-02-02 2002-08-19 Mount Sinai Hospital Human acid phosphatase gene
US20030166041A1 (en) * 2001-02-08 2003-09-04 Hillman Jennifer L. TIMM8b-related protein
US7601825B2 (en) 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
US7118912B2 (en) 2002-08-26 2006-10-10 Case Western Reserve University Methods and compositions for categorizing patients
US7081516B2 (en) 2002-08-26 2006-07-25 Case Western Reserve University Methods for categorizing patients
US20060035237A1 (en) 2002-08-26 2006-02-16 Markowitz Sanford D Methods and compositions for categorizing patients
US6924358B2 (en) 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
WO2002085943A2 (fr) * 2001-03-05 2002-10-31 Aventis Pharma S.A. Acides nucleiques du gene abcc12 humain, vecteurs contenant ces acides nucleiques et utilisations associees
EP1572864A4 (fr) 2001-03-08 2008-02-13 Immunex Corp Polypeptides du type serpine humaine
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
US8647826B2 (en) 2001-03-14 2014-02-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
WO2002074906A2 (fr) * 2001-03-16 2002-09-26 Eli Lilly And Company Proteines de mammiferes lp et reactifs associes
US6551809B2 (en) * 2001-03-20 2003-04-22 Applera Corporation Isolated human phosphatase proteins, nucleic acid molecules encoding human phophatase proteins, and uses thereof
US20040146964A1 (en) * 2001-03-21 2004-07-29 Maxwell Patrick Henry Assays, methods and means
EP1370580A2 (fr) * 2001-03-23 2003-12-17 Universität Zürich Un nouveau composant aval essentiel du chemin de signalisation des apt res
US20040157282A1 (en) * 2001-03-23 2004-08-12 Zhimin Zhu Regulation of human dual specificity protein phosphatase 7-like protein
CA2442089A1 (fr) * 2001-03-27 2002-10-03 Dendreon San Diego Llc Molecules d'acide nucleique codant une serine protease transmembranaire 9, polypeptides codes et procedes fondes sur ces derniers
JPWO2002081515A1 (ja) * 2001-04-03 2004-07-29 協和醗酵工業株式会社 インスリン様増殖因子結合蛋白質
CA2443393A1 (fr) 2001-04-03 2002-11-07 Bristol-Myers Squibb Company Polynucleotide codant pour une nouvelle cysteine protease de la superfamille calpain, can-12 et leurs variantes
WO2002083928A2 (fr) 2001-04-10 2002-10-24 Agensys, Inc. Acide nucleique et proteine correspondante intitule 158p3d2 utiles dans le traitement et la detection du cancer
EP2280030A3 (fr) 2001-04-10 2011-06-15 Agensys, Inc. Acides nucléiques et protéines correspondantes utiles dans la détection et le traitement des différents cancers
DK1573022T3 (da) 2001-04-10 2011-09-12 Agensys Inc Nukleinsyre og tilsvarende protein betegnet 184P1E2, der er egnede til behandling og påvisning af cancer
US20030191073A1 (en) 2001-11-07 2003-10-09 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
US7309760B2 (en) * 2001-04-17 2007-12-18 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
WO2002083866A2 (fr) * 2001-04-17 2002-10-24 The Board Of Trustees Of The University Of Arkansas Sequences repetees du gene ca125 et leurs utilisations dans des interventions diagnostiques et therapeutiques
WO2002088312A2 (fr) * 2001-04-26 2002-11-07 Pe Corporation (Ny) Proteines secretee par l'humain isolee, molecules d'acide nucleique codant les proteines secretees par l'humain et leurs utilisations
US7713526B2 (en) * 2001-05-01 2010-05-11 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
AU2002308557A1 (en) 2001-05-01 2002-11-11 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
WO2002090567A2 (fr) 2001-05-03 2002-11-14 Children's Medical Center, Corporation Canal cationique specifique du sperme, et utilisations correspondantes
US7217785B2 (en) * 2001-05-09 2007-05-15 The Regents Of The University Of California Cysteine-containing peptides having antioxidant properties
US20040152092A1 (en) * 2001-05-11 2004-08-05 Alex Smolyar Regulation of human phosphatidic acid phosphatase type 2c-like protein
US7304034B2 (en) 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
JP2005512507A (ja) * 2001-05-15 2005-05-12 ノース・ショア−ロング・アイランド・ジューイッシュ・リサーチ・インスティテュート 抗炎症剤としてのｈｍｇフラグメントの使用
US7220723B2 (en) 2001-05-15 2007-05-22 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
WO2002095002A2 (fr) * 2001-05-22 2002-11-28 University Of Chicago Arn polymerase dependant de l'adn a brin unique de virion n4
US7157558B2 (en) 2001-06-01 2007-01-02 Genentech, Inc. Polypeptide encoded by a polynucleotide overexpresses in tumors
JP2004532640A (ja) * 2001-06-05 2004-10-28 オークランド ユニサーヴィスィズ リミテッド 肺機能および障害の評価のための方法および組成物
CA2448112A1 (fr) * 2001-06-05 2002-12-12 Exelixis Inc. Lce utilises comme modificateurs de la voie p53 et procede d'utilisation
WO2003008450A1 (fr) * 2001-06-12 2003-01-30 Kyogo Itoh Antigenes tumoraux
US20030009024A1 (en) * 2001-06-13 2003-01-09 Millennium Pharmaceuticals, Inc. 46584, a human transporter family member and uses therefor
JP2004531268A (ja) * 2001-06-14 2004-10-14 レキシコン・ジェネティクス・インコーポレーテッド 新規ヒトトランスポータータンパクおよびそれをコードするポリヌクレオチド
US20030143668A1 (en) * 2001-06-18 2003-07-31 National Institute Of Advanced Industrial Guanosine triphosphate-binding protein coupled receptors
ITMI20011465A1 (it) * 2001-07-10 2003-01-10 Novuspharma Spa Gene ad attivita' oncosoppressiva
WO2003006688A2 (fr) * 2001-07-13 2003-01-23 University Of Aarhus Methodes de diagnostic et de traitement des maladies associees a l'expression alteree de gnas
JP2003024080A (ja) * 2001-07-19 2003-01-28 Univ Tokyo ｐ５３依存性アポトーシス誘導タンパク質、およびアポトーシス調節剤のスクリーニング方法
WO2003008446A1 (fr) * 2001-07-19 2003-01-30 Mitsubishi Pharma Corporation Polypeptides se rapportant au transfert de signaux de recepteur de produits terminaux a glycation avancee
WO2003010198A1 (fr) * 2001-07-26 2003-02-06 Kenton Srl Identification d'antigenes tumoraux specifiques par selection de bibliotheques d'adnc avec des serums et utilisation de ces antigenes dans des techniques de diagnostic
AU2002319703A1 (en) 2001-07-27 2003-02-17 Wyeth Aggrecanase molecules
US6887687B2 (en) 2001-07-30 2005-05-03 Immunex Corporation Nucleic acids encoding human ataxin-1-like polypeptide IMX97018
FR2828209A1 (fr) * 2001-08-01 2003-02-07 Cytomics Systems Acides nucleiques codant de nouvelles proteines a domaine hect, leurs utilisations en diagnostics et en therapie
US7358349B2 (en) 2001-08-24 2008-04-15 Hisamitsu Pharmaceutical Co., Inc. Nucleic acids having expression differentials between hepatoblastoma and normal liver
JP2003135063A (ja) * 2001-08-24 2003-05-13 Chiba Prefecture 新規な遺伝子ｎｅｄｌ−１
CA2458915A1 (fr) 2001-08-31 2003-03-13 Agensys, Inc. Acide nucleique et proteine correspondante appelee 205p1b5 utiles dans le traitement et la detection du cancer
JP2005505271A (ja) 2001-09-06 2005-02-24 アジェンシス， インコーポレイテッド 癌の処置および検出において有用なｓｔｅａｐ−１と名称が与えられる核酸および対応するタンパク質
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
AU2002325088C1 (en) * 2001-09-14 2008-09-25 Clinical Genomics Pty. Ltd. Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
US20050222070A1 (en) 2002-05-29 2005-10-06 Develogen Aktiengesellschaft Fuer Entwicklungsbiologische Forschung Pancreas-specific proteins
AU2002326957B2 (en) 2001-09-19 2006-08-10 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Transductin-1 and transductin-2 and applications to hereditary deafness
JP2003093056A (ja) * 2001-09-26 2003-04-02 Japan Science & Technology Corp ｐ５３のＳｅｒ４６をリン酸化する酵素
US20030108928A1 (en) * 2001-10-09 2003-06-12 Millennium Pharmaceuticals, Inc. MID 241 receptor, a novel G-protein coupled receptor
CN1596264A (zh) * 2001-10-16 2005-03-16 奥托根研究股份有限公司 有关肥胖及2型糖尿病的差异表达基因
US20030100034A1 (en) * 2001-10-16 2003-05-29 Millennium Pharmaceuticals, Inc. 9136, a human aldehyde dehydrogenase family member and uses therefor
DE10152598A1 (de) * 2001-10-19 2003-05-22 Schering Ag ARL-2-für die Fertilitätskontrolle
US8729248B2 (en) 2001-10-22 2014-05-20 Children's Medical Center Corporation Sperm-specific cation channel, CATSPER2, and uses therefor
WO2003054141A2 (fr) * 2001-10-22 2003-07-03 Children's Medical Center Corporation Canal cations catsper2 specifique du sperme et utilisations correspondantes
DE10153259A1 (de) * 2001-10-31 2003-05-22 Osram Opto Semiconductors Gmbh Optoelektronisches Bauelement
CA2460283A1 (fr) * 2001-10-31 2003-05-08 Pfizer Products Inc. Solutions therapeutiques et diagnostiques pour les troubles de l'erythropoiese
AU2002359331A1 (en) * 2001-10-31 2003-06-10 Millennium Pharmaceuticals, Inc. Methods and compositions for the treatment and diagnosis of cellular proliferative disorders using 32222
EP1537140B1 (fr) 2001-11-07 2013-01-02 Agensys, Inc. Acide nucleique et proteine correspondante 161p2f10b utiles dans le traitement et le depistage du cancer
EP1442118A2 (fr) * 2001-11-08 2004-08-04 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Proteine men, gst2, rab-rp1, csp, proteine a f-box lilina/fbl7, abc50, coronine, sec61 alpha ou vhappa1-1 ou proteines homologues jouant un role dans la regulation de l'homeostasie energetique
WO2003042370A2 (fr) * 2001-11-14 2003-05-22 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nouveau gene exprime dans le cancer de la prostate et techniques d'utilisation
US7074576B2 (en) * 2001-11-23 2006-07-11 Syn X Pharma, Inc. Protein biopolymer markers indicative of alzheimer's disease
US20030100016A1 (en) * 2001-11-23 2003-05-29 George Jackowski Complement C3 precursor biopolymer markers predictive of Alzheimers disease
AU2002352145A1 (en) * 2001-11-26 2003-06-10 Bayer Healthcare Ag Regulation of human aldose reductase-like protein
ES2605445T3 (es) 2001-11-26 2017-03-14 Hivih Interacciones proteína-proteína en el virus de la inmunodeficiencia humana
EP1318406B1 (fr) * 2001-12-04 2005-11-09 B.R.A.H.M.S Aktiengesellschaft Utilisation de la Glycine-N-Acyl-Transférase (GNAT) pour le diagnostic des maladies inflammatoires et de la septicémie
US20060275747A1 (en) * 2001-12-07 2006-12-07 Hardy Stephen F Endogenous retrovirus up-regulated in prostate cancer
WO2003050258A2 (fr) * 2001-12-07 2003-06-19 Chiron Corporation Polypeptides de retrovirus endogenes lies a la transformation oncogenique
AU2002366631A1 (en) * 2001-12-10 2003-06-23 Amersham Plc Human prostate cancer candidate protein 1
EP1480994A1 (fr) * 2001-12-14 2004-12-01 Incyte Genomics, Inc. Proteines associees a la neurotransmission
AU2002357147A1 (en) * 2001-12-14 2003-06-30 Incyte Genomics, Inc. Transporters and ion channels
US7858297B2 (en) * 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
CA2471777A1 (fr) * 2001-12-18 2003-06-26 Endocube Sas Nouvelles proteines associees a la mort, et mecanismes d'action de thap1 et para4 dans la maitrise de l'apoptose
JP3837524B2 (ja) 2001-12-19 2006-10-25 国立大学法人 長崎大学 核酸、当該核酸からなるプローブ、及び当該プローブを用いたスクリーニング法
JP2003245084A (ja) 2001-12-20 2003-09-02 Morinaga Milk Ind Co Ltd 脳梁又は精子の形成不全の診断及び治療に有用な新規遺伝子、並びにその用途
AU2002357347A1 (en) * 2001-12-21 2003-07-30 Ramot At Tel Aviv University Ltd. Chromatin remodeling protein as a marker expressed by stromal progenitor cells
GB0130720D0 (en) * 2001-12-21 2002-02-06 Serono Internat S A Proteins
US20050112618A1 (en) * 2001-12-21 2005-05-26 Fagan Richard J. Secreted protein
AU2003210158A1 (en) * 2002-01-16 2003-07-30 Bayer Aktiengesellschaft Regulation of human fatty acid coa ligase-like amp-binding enzyme
WO2003060129A1 (fr) * 2002-01-16 2003-07-24 Bayer Healthcare Ag Regulation d'enzyme de liaison amp du type coa ligase d'acides gras humains
AU2003214882A1 (en) * 2002-01-23 2003-09-02 Mayo Foundation For Medical Education And Research Polycystic kidney disease nucleic acids and proteins
WO2003062429A1 (fr) * 2002-01-23 2003-07-31 Yamanouchi Pharmaceutical Co., Ltd. Nouvelle serine protease
GB0202149D0 (en) * 2002-01-30 2002-03-20 Univ Edinburgh Pluripotency determining factors and uses thereof
WO2003064469A2 (fr) * 2002-02-01 2003-08-07 Bayer Healthcare Ag Regulation de la proteine du type de recepteur hematopoietique humain
CA2477159A1 (fr) * 2002-02-20 2003-08-28 Invitrogen Corporation Marqueurs moleculaires hautement homogenes pour electrophorese
EP1338606A1 (fr) * 2002-02-22 2003-08-27 Magnus Von Knebel Doeberitz Molecules d'acide nucleique codant de HERV-H polypeptide de diagnostic du cancer colorectal
GB2388113A (en) * 2002-03-06 2003-11-05 Oxford Glycosciences B-cell malignancy-associated protein
JP2003259872A (ja) * 2002-03-07 2003-09-16 Japan Science & Technology Corp ヒト食道癌抗原ペプチドと食道癌診断方法
CN1507492A (zh) * 2002-03-07 2004-06-23 株式会社Bf研究所 p18AβrP基因和 p18AβrP蛋白、通过与所述基因 /蛋白相互作用抑制细胞死亡的新型基因 /蛋白 ( p 60TRP)和促进细胞死亡的物质
KR100746141B1 (ko) * 2002-03-08 2007-08-06 에자이 알앤드디 매니지먼트 가부시키가이샤 전시냅스성 단백질 р120
DE10211088A1 (de) 2002-03-13 2003-09-25 Ugur Sahin Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
AU2012216265B2 (en) * 2002-03-13 2015-01-22 Biontech Ag Genetic products differentially expressed in tumors and use thereof
DE60329988D1 (de) * 2002-03-14 2009-12-24 Nat Inst Of Advanced Ind Scien N-acetylglucosamin-transferase, diese codierende nukleinsäure sowie verwendung davon bei der diagnose von krebs und/oder einem tumor
WO2003083078A2 (fr) 2002-03-28 2003-10-09 Bristol-Myers Squibb Company Nouvelle proteine de surface cellulaire avec replis d'hemoglobine, bgs-19
US20040002593A1 (en) * 2002-04-04 2004-01-01 Reed John C. PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use
US7544767B2 (en) * 2002-04-05 2009-06-09 Burnham Institute For Medical Research HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
AU2003222965A1 (en) * 2002-04-05 2003-10-27 University Court Of The University Of Edinburgh Schizophrenia associated genes
AU2003222189A1 (en) * 2002-04-05 2003-10-27 Incyte Corporation Secreted proteins
WO2003087332A2 (fr) 2002-04-12 2003-10-23 Bristol-Myers Squibb Company Nouveaux polynucleotides codant le polypeptide kinase citron humain, bmsnkc 0020/0021
CA2482598C (fr) * 2002-04-22 2012-09-25 The Board Of Trustees Of The Leland Stanford Junior University Inhibiteurs peptidiques de la proteine kinase c
EP1576096A4 (fr) * 2002-04-23 2007-05-23 Univ Georgia Res Found Sequence de codage de n-acetylglucosaminyltransferase vb, cellules recombinantes et procedes associes
US20060160728A1 (en) * 2002-04-26 2006-07-20 Heinz Von Der Kammer Diagnostic and therapeutic use of ensandin-0138 gene and protein for neurodegenerative diseases
WO2004044125A2 (fr) * 2002-05-15 2004-05-27 Incyte Corporation Proteines associees a la vesicule
EP1365032B1 (fr) * 2002-05-21 2008-11-19 MTM Laboratories AG Marqueurs associés avec des tumeurs pulmonaires
EP2275118A3 (fr) * 2002-05-29 2011-10-19 DeveloGen Aktiengesellschaft Proteines specifiques du pancreas
WO2003104275A2 (fr) 2002-06-06 2003-12-18 Oncotherapy Science, Inc. Genes et polypeptides en rapport avec les cancers du colon chez l'homme
AU2003251425A1 (en) * 2002-06-06 2003-12-22 The Trustees Of Columbia University In The City Of New York Mahoganoid polypeptides, and related compositions and methods
CA2487077A1 (fr) * 2002-06-10 2003-12-18 Merck & Co., Inc. Molecule d'acide nucleique isolee codant une proteine de type moteur associee a un centromere, et ses utilisations
CA2489292A1 (fr) * 2002-06-13 2003-12-24 Chiron Corporation Vecteurs pour l'expression de polypeptides hml-2
WO2004000883A1 (fr) * 2002-06-24 2003-12-31 Bayer Healthcare Ag Regulation du recepteur de l'hormone liberant l'hormone de croissance humaine
AU2003278569A1 (en) * 2002-06-25 2004-01-06 Tao Biosciences, Llc Methods for identifying antimicrobial agents, the agents identified therewith and methods of using same
FR2841261B1 (fr) * 2002-06-25 2004-08-27 Univ Pasteur Compositions et methodes pour detecter les pathologies affectant la transmission neuromusculaire
WO2004005541A1 (fr) * 2002-07-09 2004-01-15 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Tests diagnostiques permettant de detecter une neuropathie peripherique
AU2003253930A1 (en) * 2002-07-11 2004-02-02 Seattle Genetics, Inc. Sga-72m, a cancer associated antigen, and uses thereof
EP1382613A1 (fr) 2002-07-16 2004-01-21 Sumitomo Chemical Company, Limited Nouvelle protéine G, son utilisation et acides nucléiques la codant
US7029673B2 (en) 2002-07-16 2006-04-18 Emory University Regulatory protein for Nox enzymes
GB0216661D0 (en) * 2002-07-17 2002-08-28 Ares Trading Sa Protein
US20040132058A1 (en) * 2002-07-19 2004-07-08 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
US7135556B2 (en) 2002-07-19 2006-11-14 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
US20050019404A1 (en) * 2003-06-30 2005-01-27 Hsing-Wen Sung Drug-eluting biodegradable stent
US20050163821A1 (en) * 2002-08-02 2005-07-28 Hsing-Wen Sung Drug-eluting Biodegradable Stent and Delivery Means
AU2003258056A1 (en) 2002-08-07 2004-02-25 Children's Medical Center Corporation Sperm-specific cation channel, catsper-3, and uses therefor
AU2003263981A1 (en) 2002-08-07 2004-02-25 Children's Medical Center Corporation Sperm-specific cation channel, catsper-4, and uses therefor
WO2004089282A2 (fr) * 2002-08-09 2004-10-21 Curagen Corporation Polypeptides therapeutiques, acides nucleiques codant ces polypeptides, et procedes d'utilisation correspondants
EP1534833A4 (fr) * 2002-08-09 2006-06-07 Melbourne Health Facteurs de transcription mammiferes grainyhead
WO2004016733A2 (fr) * 2002-08-16 2004-02-26 Agensys, Inc. Acides nucleiques et proteines correspondantes connues sous 251p5g2 que l'on utilise dans le traitement et la detection de cancers
CA2496781A1 (fr) * 2002-08-26 2004-03-04 Case Western Reserve University Methodes de traitement de patients et d'identification de therapeutique
DE10242146A1 (de) * 2002-09-04 2004-03-18 Eberhard-Karls-Universität Tübingen Universitätsklinikum Antikörper zur Identifizierung und/oder Isolierung von hämatopoetischen Stammzellen
EP1575497A4 (fr) * 2002-09-11 2010-11-03 Genentech Inc Nouvelle composition et nouveaux procedes pour le traitement du psoriasis
EP1398372A1 (fr) * 2002-09-13 2004-03-17 Universitätsklinikum Charité an der Humboldt- Universität zu Berlin Lipid phosphate phosphatases et leur utilisation pour le traitement des maladies neuronales
CA2498771A1 (fr) * 2002-09-13 2004-03-25 Sankyo Company Limited 2',5'-oligoadenylate phosphodiesterase
US6892925B2 (en) * 2002-09-18 2005-05-17 International Business Machines Corporation Solder hierarchy for lead free solder joint
JP2006500032A (ja) * 2002-09-19 2006-01-05 タノックス インコーポレーテッド 活性化ｔ細胞受容体の核因子
CN1911962A (zh) * 2002-09-27 2007-02-14 奥里迪斯生物医学研究及开发有限责任公司 多肽与编码这些多肽的核酸和它们用于预防、诊断或治疗肝脏失调和上皮癌的用途
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
WO2004033636A2 (fr) * 2002-10-04 2004-04-22 Incyte Corporation Molecules de modification et de maintien de proteines
WO2004089984A1 (fr) 2002-10-04 2004-10-21 Mitsubishi Pharma Corporation Anticorps reconnaissant un antigène
EP1575518A4 (fr) 2002-10-10 2007-08-22 Wyeth Corp Compositions, organismes et methodologies utilisant une nouvelle kinase humaine
GB0224116D0 (en) * 2002-10-16 2002-11-27 Ares Trading Sa Proteins
CA2503491A1 (fr) * 2002-10-24 2004-05-06 Wyeth Compositions, organismes et procedes faisant appel a une nouvelle proteine phosphatase humaine
AU2003279312A1 (en) * 2002-10-24 2004-05-13 Evotec Neurosciences Gmbh Diagnostic and therapeutic use of ensadin-0289 gene and protein for neurodegenerative diseases
EP1557178A4 (fr) * 2002-10-29 2009-07-22 Takeda Pharmaceutical Utilisation de l'homologue de sglt
AU2003290582A1 (en) * 2002-11-04 2004-06-07 Florida State University Research Foundation NUCLEIC ACID AND ALLERGENIC POLYPEPTIDES ENCODED THEREBY IN CASHEW NUTS (Anacardium occidentale)
WO2004044205A1 (fr) * 2002-11-11 2004-05-27 Korea Chungang Educational Foundation Promoteur d'expression specifique a la semence de plantes derive du sesame et vecteur d'expression specifique a la semences de plantes comprenant ce promoteur
US7405289B2 (en) * 2002-11-13 2008-07-29 Metabolex, Inc. Pancreatic islet transcription factor and uses thereof
WO2004043403A2 (fr) * 2002-11-13 2004-05-27 The Uab Research Foundation Polypeptides synthetiques a domaine unique imitant l'apolipoproteine e et methodes d'utilisation
JP2006516388A (ja) * 2002-11-21 2006-07-06 ワイス ループス腎炎の治療用組成物および方法
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
MXPA05005539A (es) 2002-11-26 2006-02-10 Univ Tennessee Res Foundation Molecula de adhesion streptococcus uberis.
US7297525B2 (en) 2002-11-27 2007-11-20 Wyeth Composition employing a novel human kinase
EP1567552A2 (fr) * 2002-12-04 2005-08-31 Applied Research Systems ARS Holding N.V. Nouveaux polypeptides analogues a l'ifn gamma
US6854636B2 (en) * 2002-12-06 2005-02-15 International Business Machines Corporation Structure and method for lead free solder electronic package interconnections
US7465581B2 (en) * 2002-12-18 2008-12-16 The Scripps Research Institute ANKTM1, a cold-activated TRP-like channel expressed in nociceptive neurons
US20050049214A1 (en) * 2003-01-15 2005-03-03 Chiron Corporation Inhibition of E3-ubiquitin ligase HAKAI for treatment of proliferative disorders
AU2007231823B2 (en) * 2003-01-24 2011-07-21 Agensys, Inc. Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer
EP1590437A4 (fr) 2003-01-24 2008-06-18 Agensys Inc Acides nucleiques et proteines correspondantes dites 254p1d6b utiles pour la detection et le traitement du cancer
US7304036B2 (en) * 2003-01-28 2007-12-04 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2004069174A2 (fr) * 2003-01-31 2004-08-19 Slil Biomedical Corporation Suivi et de traitement de la sclerose laterale amyotrophique
AU2004293369A1 (en) 2003-03-03 2005-06-09 Genentech, Inc. Compositions and methods for the treatment of systemic lupus erythematosis
EP1923400A1 (fr) * 2003-03-03 2008-05-21 Genentech, Inc. Compositions et procédés pour le traitement de lupus érythémateux systémique
US7521534B1 (en) * 2003-03-03 2009-04-21 The University Board Of Regents Of Texas System IKK gamma gene products and methods for making and using same
WO2004081199A2 (fr) * 2003-03-11 2004-09-23 Genentech, Inc. Nouvelles compositions et methodes de traitement de troubles du systeme immunitaire
US20080081841A1 (en) * 2003-03-20 2008-04-03 Badache Ali Materials and Methods for Modulating Cell Motility
EP1464651A1 (fr) * 2003-04-03 2004-10-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Protéine associée à la distrophine (Drop1) utilisée comme marqueur por le cancer
EP1651667B1 (fr) * 2003-04-04 2012-03-28 Centre National De La Recherche Scientifique Proteine a activite fusogene, sequences d'acides nucleiques codant cette proteine et compositions pharmaceutiques les contenant
US7572887B2 (en) 2003-04-08 2009-08-11 The United States Of America As Represented By The Department Of Health And Human Services Gene expressed in prostate cancer, methods and use thereof
WO2004094651A2 (fr) * 2003-04-18 2004-11-04 Five Prime Therapeutics, Inc. Nouveaux polypeptides humains codes par des polynucleotides
US20050032695A1 (en) * 2003-05-30 2005-02-10 Aventis Pharma Deutschland Gmbh Method for alleviating pain using protein associated with MYC and related compounds, and assays for identifying such compounds
US7696169B2 (en) 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
FR2843753A1 (fr) * 2003-06-20 2004-02-27 Gene Signal Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
EP1636379A2 (fr) * 2003-06-26 2006-03-22 Exonhit Therapeutics S.A. Genes specifiques de la prostate et leur utilisation comme cibles dans le traitement et le diagnostic du cancer de la prostate
FR2857098B1 (fr) * 2003-07-04 2006-05-05 Inst Nat Sante Rech Med Procede de mise en evidence d'un evenement moleculaire dans une cellule grace a des proteines marqueurs fluorescentes.
GB0315827D0 (en) * 2003-07-05 2003-08-13 Imp College Innovations Ltd Methods
US20070066801A1 (en) * 2003-07-14 2007-03-22 Engler Jeffrey A Identification of reagents for the diagnosis and study of francisella
EP1507004A1 (fr) * 2003-08-14 2005-02-16 DKFZ Deutsches Krebsforschungszentrum Méthode pour l'inhibition de propagation d'une population de cellules indésirables
AU2003275958A1 (en) * 2003-08-25 2005-03-10 Pieris Proteolab Ag Muteins of tear lipocalin
EP1660651A2 (fr) * 2003-09-04 2006-05-31 Applied Research Systems ARS Holding N.V. Polypeptides d'ubp8rp et leur utilisation dans le traitement de psoriasis
US8283307B2 (en) 2003-09-08 2012-10-09 Merck Serono Sa Treatment of fibrotic disease
DE10341812A1 (de) * 2003-09-10 2005-04-07 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
WO2005026209A2 (fr) 2003-09-11 2005-03-24 Critical Therapeutics, Inc. Anticorps monoclonaux diriges contre hmgb1
JP4634302B2 (ja) * 2003-09-30 2011-02-16 第一三共株式会社 テトラヒドロ葉酸合成酵素遺伝子
US20050136451A1 (en) * 2003-10-06 2005-06-23 Li Yan Hypoxia responsive human CNGH 0002 genes and polypeptides
US7431915B2 (en) * 2003-10-31 2008-10-07 The Regents Of The University Of California Peptides whose uptake by cells is controllable
US7985401B2 (en) 2003-10-31 2011-07-26 The Regents Of The University Of California Peptides whose uptake by cells is controllable
CN100434437C (zh) * 2003-11-19 2008-11-19 康哲医药研究(深圳)有限公司 包含异亮氨酰-缬氨酰-苏氨酰-天冬酰胺酰-苏氨酰-苏氨酸的生物活性肽
US20050255560A1 (en) * 2003-11-21 2005-11-17 Zeren Gao Ztnf11, a tumor necrosis factor
WO2005051999A2 (fr) * 2003-11-26 2005-06-09 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Substance se liant au récepteur humain iib pour le fc des igg (fc$g(g)riib)
WO2005056801A1 (fr) * 2003-12-15 2005-06-23 Genesis Research And Development Corporation Limited Polynucleotides et polypeptides isoles dans lactobacillus rhamnosus hn001, matieres les contenant et leurs methodes d'utilisation
GB0329958D0 (en) * 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
CA2553769C (fr) 2004-01-16 2011-01-04 Merck & Co., Inc. Npc1l1 (npc3) et procedes pour identifier des ligands de ceux-ci
JP2007524413A (ja) 2004-01-28 2007-08-30 エクセリクシス， インク． ＩＧＦＲ経路のモディファイヤーとしてのＭＡＮ２Ａｓ及び使用方法
US7148192B2 (en) * 2004-01-29 2006-12-12 Ebwe Pharma Ges. M.H. Nfg.Kg Neuroprotective dietary supplement
US20050255530A1 (en) * 2004-02-06 2005-11-17 Keefer Carol L Identification and isolation of pluripotency determining factors
GB0403142D0 (en) * 2004-02-12 2004-03-17 Ares Trading Sa Protein
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
CA2560066A1 (fr) 2004-03-01 2005-09-15 The Cbr Institute For Biomedical Research, Inc. Anticorps naturels igm et leurs inhibiteurs
US7166433B2 (en) * 2004-03-03 2007-01-23 The United States Of America As Represented By The Department Of Health And Human Services Transductin-1 and transductin-2 and applications to hereditary deafness
US20070254283A1 (en) * 2004-03-04 2007-11-01 Roy Deudutta Brhf1 as a Cancer Diagnostic Marker
US20080050315A1 (en) * 2004-03-24 2008-02-28 Stefan Golz Diagnostics and Therapeutics for Diseases Associated with Protein Kinase, Cgmp-Dependent, Type I (Prkg1)
WO2005098440A2 (fr) * 2004-03-26 2005-10-20 Immusol, Inc. Procedes permettant d'identifier des agents servant au traitement de maladies neurodegeneratives
EP2070546A1 (fr) 2004-04-09 2009-06-17 Takeda Pharmaceutical Company Limited Agents préventifs/remèdes pour le cancer
WO2005108563A2 (fr) * 2004-04-19 2005-11-17 University Of Chicago Proteine hydrolysant le peptidoglycane encodée par bacteriophage n4
SI1742966T1 (sl) 2004-04-22 2014-03-31 Agensys, Inc. Protitelesa in iz njih izvedene molekule, ki se veĹľejo na STEAP-1 proteine
CA2810292C (fr) * 2004-05-14 2015-09-29 Euroscreen S.A. Ligand pour recepteur fprl2 couple aux proteines g et leur utilisation
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
JP4649575B2 (ja) * 2004-05-19 2011-03-09 財団法人ヒューマンサイエンス振興財団 新規ムチン遺伝子及び粘膜関連疾患の診断
WO2005114200A1 (fr) * 2004-05-21 2005-12-01 Bayer Healthcare Ag Diagnostic et therapeutique de pathologies en rapport avec une kinase 7 associee au recepteur couple a une proteine g (grk7)
EP2031063B1 (fr) 2004-06-18 2013-11-06 Duke University Modulateurs de récepteurs odorants
CA2559760A1 (fr) * 2004-07-02 2006-07-06 Metanomics Gmbh Procede de production de produits chimiques fins
EP2287310B1 (fr) 2004-07-22 2015-05-06 Five Prime Therapeutics, Inc. Compositions et procedes d'utilisation de MGD-CSF dans le traitement de maladies
WO2006022689A1 (fr) * 2004-08-06 2006-03-02 Applera Corporation Procédé et compositions destinés au traitement des maladies ciblant cd51
US8435507B2 (en) 2004-08-19 2013-05-07 University Of Maryland Prostate-specific antigen-derived MHC class II restricted peptides and their use in vaccines to treat or prevent prostate cancer
EP1804830A2 (fr) * 2004-09-08 2007-07-11 The Ludwig Institute for Cancer Research Antigenes du cancer du testicule
ATE479778T1 (de) 2004-09-24 2010-09-15 Oncotherapy Science Inc Verfahren zur diagnose nicht-kleinzelliger lungenkarzinome über die trna-dihydrouridin- synthaseaktivität von urlc8
US9944713B2 (en) * 2004-11-24 2018-04-17 Medicinal Bioconvergence Research Center Antibody specific to the AIMP2-DX2
US20100111980A1 (en) * 2004-12-10 2010-05-06 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Binding partners of antibodies specific for dendritic cell antigens
DE102004059781A1 (de) * 2004-12-10 2006-06-22 Sanofi-Aventis Deutschland Gmbh Verwendung der Serum-/Glucocorticoid regulierten Kinase
US7973140B2 (en) 2004-12-21 2011-07-05 Medimmune Limited Antibodies directed to angiopoietin-2 and uses thereof
WO2006090389A2 (fr) 2005-02-24 2006-08-31 Compugen Ltd. Nouveaux marqueurs diagnostiques, en particulier pour l'imagerie in vivo, et dosage et procedes d'utilisation associes
US8350009B2 (en) 2005-03-31 2013-01-08 Agensys, Inc. Antibodies and related molecules that bind to 161P2F10B proteins
CA2603093A1 (fr) 2005-03-31 2006-10-05 Agensys, Inc. Anticorps et molecules correspondantes qui se fixent aux proteines 161p2f10b
WO2006111586A2 (fr) * 2005-04-20 2006-10-26 Proyecto De Biomedicina Cima, S.L. Procede permettant de determiner in vitro le degre de methylation du promoteur de line-1
US20060281114A1 (en) * 2005-05-19 2006-12-14 Young Robert P Methods and compositions for assessment of pulmonary function and disorders
EP1888777A4 (fr) * 2005-05-19 2008-11-26 Synergenz Bioscience Ltd Procédés et compositions d'évaluation des fonctions et troubles pulmonaires
US7933722B2 (en) * 2005-05-20 2011-04-26 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
US8080632B2 (en) 2005-09-01 2011-12-20 The Feinstein Institute For Medical Research Peptide mimics of melanocyte stimulating hormone
WO2007035474A2 (fr) * 2005-09-15 2007-03-29 Novomed Technologies, Inc. (Shanghai) Peptides d'administration transdermique et procede d'utilisation de ceux-ci
US7659252B2 (en) 2005-09-15 2010-02-09 Novomed Technologies, Inc. (Shanghai) Transdermal delivery peptides and method of use thereof
US20080090775A1 (en) * 2005-10-31 2008-04-17 Chong Huang Antagonist of TEB4 and Methods of Use
EP1790664A1 (fr) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
WO2007087412A2 (fr) * 2006-01-25 2007-08-02 Thallion Pharmaceuticals, Inc. Tat-036 et méthodes d'évaluation et de traitement du cancer
EP1996614A1 (fr) 2006-01-30 2008-12-03 The Ludwig Institute for Cancer Research Antigenes ctsp du cancer du testicule
CA2638807A1 (fr) * 2006-02-01 2007-08-09 The Burnham Institute For Medical Research Codes lymphatiques dans des tumeurs et lesions pre-malignes
WO2007101063A2 (fr) 2006-02-22 2007-09-07 Zhu M D Zhenglun Traitement de troubles liés au développement
US7910698B2 (en) 2006-02-24 2011-03-22 Schering Corporation NPC1L1 orthologues
AU2007224704B2 (en) * 2006-03-13 2012-12-06 Novovacs Holding B.V. Cancer vaccine
US7811787B2 (en) * 2006-04-25 2010-10-12 Bristol-Myers Squibb Company Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3
JP5564249B2 (ja) * 2006-06-23 2014-07-30 アレシア・バイオセラピューティクス・インコーポレーテッド 癌に関与するポリヌクレオチド配列およびポリペプチド配列
SG174071A1 (en) 2006-08-10 2011-09-29 Oncotherapy Science Inc Genes and polypeptides relating to breast cancers
EP2695896B1 (fr) 2006-10-06 2018-08-22 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Prévention de l'ischémie tissulaire et méthodes et compositions associées
ES2636089T3 (es) 2006-10-27 2017-10-05 Genentech, Inc. Anticuerpos e inmunoconjugados y usos para los mismos
EP2052085B1 (fr) * 2006-12-21 2019-05-22 Cognosci, Inc. Procédés de modulation de set et utilisations associées
JPWO2008114672A1 (ja) * 2007-03-15 2010-07-01 株式会社リバース・プロテオミクス研究所 がんに特異的なバイオマーカー
WO2008121007A1 (fr) * 2007-03-29 2008-10-09 Auckland Uniservices Limited Nouveaux polypeptides et polynucléotides saratan et leurs procédés d'utilisation
US7951595B2 (en) * 2007-03-30 2011-05-31 National University Corporation Okayama University Methods for screening modulators of SLC17-type anion transport activity
US20100249038A1 (en) * 2007-06-12 2010-09-30 Board Of Regents, University Of Texas System Antagonists of the receptor for advanced glycation end-products (rage)
FR2919616A1 (fr) * 2007-08-02 2009-02-06 Ecole Norm Superieure Lyon Polynucleotides insulateurs derives de l'element d4z4 et leurs utilisations en transgenese
US8163874B2 (en) * 2007-08-06 2012-04-24 The United States Of America, As Represented By The Secretary Of The Navy Beta helical peptide structures stable in aqueous and non-aqueous media and methods for preparing same
AU2008285655B2 (en) * 2007-08-09 2012-03-08 Novartis Ag Thiopeptide precursor protein, gene encoding it and uses thereof
CA3128656A1 (fr) 2007-08-22 2009-02-26 The Regents Of The University Of California Polypeptides de liaison activables et procedes d'identification et utilisation de ceux-ci
KR20100063719A (ko) * 2007-08-24 2010-06-11 라모트 앳 텔-아비브 유니버시티 리미티드 Ｎａｐ 유사 및 ｓａｌ 유사 펩티드 모의체를 사용한 신경보호
US9422363B2 (en) 2007-08-28 2016-08-23 Uab Research Foundation Synthetic apolipoprotein E mimicking polypeptides and methods of use
DE102007041657A1 (de) * 2007-09-03 2009-03-05 Protagen Ag Markersequenzen für Multiple Sklerose und deren Verwendung
JP5295242B2 (ja) * 2007-09-04 2013-09-18 プロセル セラピューティックス インコーポレーティッド 細胞透過性Ｎｍ２３組換えタンパク質、これをコードするポリヌクレオチド及びこれを有効成分として含有する癌転移抑制用組成物
EP2198306A1 (fr) 2007-09-06 2010-06-23 Case Western Reserve University Procédés de diagnostic et de traitement de cancers
US8802631B2 (en) * 2007-09-17 2014-08-12 Ludwig Institute For Cancer Research Ltd. Peptides and methods for the treatment of gliomas and other cancers
AU2008301888A1 (en) * 2007-09-20 2009-03-26 R. Bradley Jones Long interspersed nuclear element polypeptide compositions and methods of use thereof
GB0719367D0 (en) 2007-10-03 2007-11-14 Procarta Biosystems Ltd Transcription factor decoys, compositions and methods
CN102076847A (zh) * 2008-05-02 2011-05-25 Epi中心科技公司 Rna多磷酸酶组合物、试剂盒及其应用
US8324165B2 (en) 2008-05-14 2012-12-04 Five Prime Therapeutics, Inc. Compositions for treating arthritis comprising HG1023575 polypeptide
WO2009149083A2 (fr) * 2008-06-03 2009-12-10 University Of Maryland, Baltimore Clya non hémolytique pour l'excrétion de protéines
EP2304444A4 (fr) * 2008-06-19 2012-04-25 Agency Science Tech & Res Modulateurs de l'interaction entre stat3 et sp1
US20100093624A1 (en) * 2008-07-30 2010-04-15 Cosmix Therapeutics Llc Peptide therapeutics that bind vegf and methods of use thereof
EP2172477A1 (fr) * 2008-10-06 2010-04-07 Atlas Antibodies AB Nouveaux épitopes et utilisations correspondantes
US8156130B2 (en) 2008-10-17 2012-04-10 Embarq Holdings Company Llc System and method for collapsing search results
US8874564B2 (en) * 2008-10-17 2014-10-28 Centurylink Intellectual Property Llc System and method for communicating search results to one or more other parties
US8326829B2 (en) * 2008-10-17 2012-12-04 Centurylink Intellectual Property Llc System and method for displaying publication dates for search results
US9333235B2 (en) 2008-10-22 2016-05-10 Trustees Of Dartmouth College Combination therapy and kit for the prevention and treatment of cystic fibrosis
WO2010048125A2 (fr) * 2008-10-22 2010-04-29 Trustees Of Dartmouth College Compositions et procédés pour inhiber l'interaction entre cftr et cal
US8999919B2 (en) 2008-10-22 2015-04-07 Trustees Of Dartmouth College Compositions and methods for inhibiting the interaction between CFTR and CAL
US9421239B2 (en) 2008-10-22 2016-08-23 Trustees Of Dartmouth College Therapy and kit for the prevention and treatment of cystic fibrosis
WO2010053717A1 (fr) * 2008-10-29 2010-05-14 William Beaumont Hospital Procédés d'utilisation de biomarqueurs
EA201100610A1 (ru) * 2008-10-30 2011-10-31 Йиссум Ресёрч Девелопмент Компани Оф Дзе Хебрю Юниверсити Оф Иерусалим Лтд. Эффективная экспрессия укороченного человеческого белка rnaset2 в e.coli
EP2362908A4 (fr) 2008-11-03 2013-09-18 Alethia Biotherapeutics Inc Anticorps qui bloquent spécifiquement l'activité biologique d'un antigène tumoral
US20110286924A1 (en) * 2008-12-09 2011-11-24 Alethia Biotherapeutics Inc Novel human endogenous retroviral erv3 variant and uses thereof in the diagnosing ovarian cancer
RU2636046C2 (ru) 2009-01-12 2017-11-17 Сайтомкс Терапьютикс, Инк Композиции модифицированных антител, способы их получения и применения
EP2398494A4 (fr) 2009-02-23 2015-10-28 Cytomx Therapeutics Inc Proprotéines et leurs procédés d'utilisation
CN102333543B (zh) * 2009-02-24 2014-05-14 国立大学法人宫崎大学 细胞粘附抑制剂及其用途
WO2010099477A2 (fr) 2009-02-27 2010-09-02 Atyr Pharma, Inc. Motifs structuraux de polypeptides associés à une activité de signalisation cellulaire
EP2408905B1 (fr) 2009-03-16 2017-05-10 Pangu Biopharma Limited Compositions et procedes comprenant des variants d'epissage d'histidyl-arnt synthetase presentant des activites biologiques non canoniques
JP5799394B2 (ja) 2009-03-18 2015-10-28 オンコセラピー・サイエンス株式会社 Ｎｅｉｌ３ペプチドおよびそれを含むワクチン
ES2560674T3 (es) * 2009-03-31 2016-02-22 Atyr Pharma, Inc. Composiciones y procedimientos que comprenden aspartil-ARNt sintetasas con actividades biológicas no canónicas
US8729239B2 (en) 2009-04-09 2014-05-20 Nuclea Biotechnologies, Inc. Antibodies against fatty acid synthase
CA2767570C (fr) 2009-07-13 2018-05-01 Universite De Montreal Isoformes mutees de la proteine sumo et leurs utilisations
EP2453926A4 (fr) 2009-07-15 2015-08-12 Univ California Peptides dont l absorption par les cellules peut être régulée
WO2011031517A1 (fr) 2009-08-27 2011-03-17 Nuclea Biotechnologies, LLC Procédé et dosage pour déterminer l'expression de fas
WO2011038066A2 (fr) * 2009-09-25 2011-03-31 Alcon Research, Ltd. Nouveaux agonistes des npr-b
AU2010298256B2 (en) 2009-09-25 2015-08-13 Takeda Pharmaceutical Company Limited Novel NPR-B agonists
WO2011040417A1 (fr) * 2009-09-29 2011-04-07 学校法人福岡大学 Protéine se liant au récepteur de l'inositol-1,4,5-triphosphate, et mammifère non-humain transgénique porteur de cette protéine
US8828395B2 (en) 2009-12-11 2014-09-09 Atyr Pharma, Inc. Antibodies that bind tyrosyl-tRNA synthetases
ES2535951T3 (es) 2009-12-11 2015-05-19 Atyr Pharma, Inc. Histidil ARNt sintetasas para reducir la inflamación
US20110150885A1 (en) * 2009-12-11 2011-06-23 Atyr Pharma, Inc. Aminoacyl trna synthetases for modulating hematopoiesis
WO2011073215A2 (fr) * 2009-12-14 2011-06-23 Immatics Biotechnologies Gmbh Peptides se liant aux hla, dérivés de molécules antigéniques associées à la prostate, et leurs procédés d'utilisation
TW201121995A (en) 2009-12-18 2011-07-01 Alcon Res Ltd Novel NPR-B agonists
DK3342786T3 (en) 2010-01-29 2021-09-27 Chugai Pharmaceutical Co Ltd Anti-dll3-antistof
CA2789230C (fr) 2010-02-08 2019-04-02 Agensys, Inc. Conjugues anticorps-medicaments (adc) qui se lient aux proteines 161p2f10b
GB201002413D0 (en) 2010-02-12 2010-03-31 Procarta Biosystems Ltd Nucleic acid complexes
JP5655254B2 (ja) * 2010-02-16 2015-01-21 国立大学法人京都工芸繊維大学 ポリカーボネートおよび／またはポリメタクリル酸メチル親和性ペプチド、およびその利用
GB201005545D0 (en) 2010-04-01 2010-05-19 Procarta Biosystems Ltd Transcription factor decoys
EP2563380B1 (fr) 2010-04-26 2018-05-30 aTyr Pharma, Inc. Découverte innovante de compositions thérapeutiques, de diagnostic et d'anticorps se rapportant à des fragments protéiques de la cystéinyl-arnt synthétase
AU2011248614B2 (en) 2010-04-27 2017-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
WO2011139801A2 (fr) 2010-04-27 2011-11-10 Atyr Pharma, Inc. Découverte innovante de compositions thérapeutiques, de diagnostic et d'anticorps se rapportant à des fragments protéiques de thréonyl arnt synthétases
EP2563911B1 (fr) 2010-04-28 2021-07-21 aTyr Pharma, Inc. Compositions thérapeutiques, diagnostiques et d'anticorps à base de fragments de protéines d'aminoacyl-arnt synthétases
US9068177B2 (en) 2010-04-29 2015-06-30 Atyr Pharma, Inc Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases
CA2797393C (fr) 2010-04-29 2020-03-10 Atyr Pharma, Inc. Decouverte innovatrice de compositions therapeutiques, diagnostiques, et d'anticorps associees aux fragments proteiques des valyle arnt synthesases
AU2011248490B2 (en) 2010-04-29 2016-11-10 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
CA2797799C (fr) 2010-05-03 2020-12-08 Atyr Pharma, Inc. Decouverte innovante de compositions therapeutiques, de diagnostic et d'anticorps liees a des fragments proteiques de seryle-arnt synthetases
EP2566515B1 (fr) 2010-05-03 2017-08-02 aTyr Pharma, Inc. Découverte innovante de compositions thérapeutiques, de diagnostic et d'anticorps liées à des fragments protéiques d'arginyle-arnt synthétases
CN103140233B (zh) 2010-05-03 2017-04-05 Atyr 医药公司 与甲硫氨酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现
US9034321B2 (en) 2010-05-03 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
US9062301B2 (en) 2010-05-04 2015-06-23 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-tRNA synthetases
CA2798139C (fr) 2010-05-04 2019-09-24 Atyr Pharma, Inc. Decouverte innovante de compositions therapeutiques, diagnostiques et a base d'anticorps liees a des fragments proteiques de complexe multi-arnt synthetase p38
EP2568996B1 (fr) 2010-05-14 2017-10-04 aTyr Pharma, Inc. Compositions thérapeutique, diagnostique et à base d'anticorps contenant des fragments protéiques de phénylalanyl-bêta-arnt synthétases
CA2799480C (fr) 2010-05-17 2020-12-15 Atyr Pharma, Inc. Decouverte innovante de compositions therapeutiques, de diagnostic, et d'anticorps associees a des fragments proteiques de leucyl-arnt synthetases
WO2011146942A1 (fr) * 2010-05-21 2011-11-24 The Translational Genomics Research Institute Procédés et kits destinés à analyser un microarn par séquençage de l'acide nucléique
CA2801237A1 (fr) 2010-05-31 2011-12-08 London Health Sciences Centre Research Inc. Peptides de liaison au recepteur a motilite mediee par l'acide hyaluronique (rhamm)
CN103118694B (zh) 2010-06-01 2016-08-03 Atyr医药公司 与赖氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现
KR20180059575A (ko) 2010-07-12 2018-06-04 에이티와이알 파마, 인코포레이티드 아스파르틸­trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견
ES2653718T3 (es) 2010-07-12 2018-02-08 Atyr Pharma, Inc. Descubrimiento innovador de composiciones terapéuticas, de diagnóstico y de anticuerpos relacionadas con fragmentos de proteínas de histidil-ARNt sintetasas
EP2593125B1 (fr) 2010-07-12 2017-11-01 aTyr Pharma, Inc. DÉCOUVERTE INNOVANTE DE COMPOSITIONS THÉRAPEUTIQUES, DE DIAGNOSTIC ET D'ANTICORPS SE RAPPORTANT À DES FRAGMENTS PROTÉIQUES DE GLYCYL-ARNt SYNTHÉTASES
US8999321B2 (en) 2010-07-12 2015-04-07 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
EP3636778B1 (fr) * 2010-08-18 2022-01-12 Fred Hutchinson Cancer Research Center Procédés pour déterminer la présence ou le risque de développer une dystrophie facioscapulohumérale (fshd)
EP2608801B1 (fr) 2010-08-25 2019-08-21 aTyr Pharma, Inc. Découverte innovante de compositions thérapeutiques, diagnostiques et d'anticorps associées à des fragments protéiniques des tyrosyl-arnt synthétases
BR112013007327A2 (pt) 2010-09-27 2017-07-04 Zestagen S A anticorpo quimérico isolado, polipeptídeo isolado, vetor de expressão, célula, métodos para produzir o anticorpo quimérico, para reduzir o crescimento e/ou a capacidade de invasão de uma célula neoplástica, para tratar um indivíduo que tem uma neoplasia, e para tratar ou prevenir a progressão de tumor ou metástase, composição farmacêutica, e, kit
UA110495C2 (en) 2010-09-29 2016-01-12 Agensys Inc Antibody drug conjugates (adc's) that bind to 191p4d12 protein
CA2812795C (fr) 2010-10-06 2021-08-31 Atyr Pharma, Inc. Decouverte innovante de fragments de proteine de tryptophanyle arnt synthetases associes a des compositions therapeutiques, diagnostiques et d'anticorps
NZ609916A (en) * 2010-12-14 2015-03-27 Immatics Biotechnologies Gmbh Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
WO2012112842A2 (fr) 2011-02-17 2012-08-23 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Compositions et procédés pour traiter le poliovirus
US10370417B2 (en) 2011-03-01 2019-08-06 Rutgers, The State University Of New Jersey Methods for the diagnosis of cancer through detection of human endogenous retrovirus WL (HERV-WL) envelope expression
WO2012118974A2 (fr) * 2011-03-01 2012-09-07 University Of Medicine And Dentistry Of New Jersey Détection d'expression de rétrovirus endogène humain dans des cellules cancéreuses et des cellules saines
CA2888908A1 (fr) 2011-03-31 2012-10-04 Alethia Biotherapeutics Inc. Anticorps contre l'antigene 1 associe aux reins et leurs fragments de liaison a l'antigene
EP2511295A1 (fr) * 2011-04-15 2012-10-17 Institut National De La Sante Et De La Recherche Medicale Compositions pour la prévention et/ou le traitement d'une infection par un virus VIH-1
KR20140059168A (ko) 2011-04-21 2014-05-15 더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 시신경 척수염 치료용 조성물 및 치료 방법
JP6124150B2 (ja) 2011-07-29 2017-05-10 アベラス バイオサイエンシーズ，インク． 選択的な送達分子及び使用方法
US9714419B2 (en) 2011-08-09 2017-07-25 Atyr Pharma, Inc. PEGylated tyrosyl-tRNA synthetase polypeptides
EP3444262A3 (fr) * 2011-09-09 2019-04-10 Agency For Science, Technology And Research Peptides activant la protéine p53
US20130084582A1 (en) 2011-10-04 2013-04-04 Err-Cheng Chan Serological markers for detecting colorectal cancer and their application for inhibiting colorectal cancer cells
JP2014532408A (ja) 2011-10-26 2014-12-08 ニュークレア バイオテクノロジーズ インコーポレイテッドＮｕｃｌｅａ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅｓ，Ｉｎｃ． ＵＳＰ２ａペプチドおよび抗体
WO2013086216A1 (fr) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Aspartyl-arnt synthétases améliorées
WO2013086228A1 (fr) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Polypeptides aspartyl-arnt synthétase pégylés
WO2013115926A2 (fr) 2011-12-29 2013-08-08 Atyr Pharma, Inc. Conjugués aspartyl-arnt synthétase-fc
JP6282597B2 (ja) 2012-01-09 2018-02-21 アー・デー・ツェー・セラピューティクス・エス・アー 乳癌を治療する方法
EP2814514B1 (fr) 2012-02-16 2017-09-13 Atyr Pharma, Inc. Histidyl-arnt synthétases pour le traitement de maladies auto-immunes et inflammatoires
WO2013167153A1 (fr) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Anticorps utiles dans le diagnostic du cancer
WO2013174404A1 (fr) 2012-05-23 2013-11-28 Ganymed Pharmaceuticals Ag Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
EP2856172A4 (fr) 2012-05-25 2016-03-02 Univ Vermont Compositions et procédés pour l'analyse de la réactivité des plaquettes et de la sélection de traitement
EP2861622A4 (fr) 2012-06-15 2016-06-01 Sinomab Bioscience Ltd Anticorps anti-idiotypiques anti-cd22 et leurs utilisations
US9957557B2 (en) * 2012-08-13 2018-05-01 Life Genetics Lab, Llc Development of a highly sensitive quantification system for assessing DNA degradation and quality in forensic samples
SG11201503593UA (en) 2012-11-13 2015-06-29 Biontech Ag Agents for treatment of claudin expressing cancer diseases
WO2014120837A2 (fr) 2013-01-29 2014-08-07 The Regents Of The University Of California Peptide à pénétration cellulaire activable pré-ciblé comportant un promédicament à libération intracellulaire
WO2014120974A1 (fr) 2013-01-30 2014-08-07 Avelas Biosciences, Inc. Distribution sélective de molécules et procédés d'utilisation
WO2014127785A1 (fr) 2013-02-20 2014-08-28 Ganymed Pharmaceuticals Ag Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
LT2961831T (lt) 2013-02-26 2020-11-10 Memorial Sloan Kettering Cancer Center Kompozicijos ir būdai, skirti imunoterapijai
CA2905940A1 (fr) 2013-03-12 2014-10-09 Decimmune Therapeutics, Inc. Anticorps humanises anti-n2
JP6628285B2 (ja) 2013-03-14 2020-01-08 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド Ａｌｓ関連ジアミノ酸リピート含有タンパク質
JP6397479B2 (ja) 2013-03-15 2018-09-26 エータイアー ファーマ， インコーポレイテッド ヒスチジル−ｔＲＮＡシンテターゼＦｃコンジュゲート
KR102466666B1 (ko) 2013-03-15 2022-11-15 메모리얼 슬로안 케터링 캔서 센터 면역치료용 조성물 및 방법
WO2014146672A1 (fr) 2013-03-18 2014-09-25 Ganymed Pharmaceuticals Ag Thérapie comprenant des anticorps dirigés contre cldn 18.2 pour le traitement du cancer
AU2014248119B2 (en) 2013-04-03 2019-06-20 Memorial Sloan-Kettering Cancer Center Effective generation of tumor-targeted T-cells derived from pluripotent stem cells
SG11201508627XA (en) * 2013-05-20 2015-11-27 Univ Nanyang Tech Peptides binding to parallel-stranded g-quadruplexes
KR101841211B1 (ko) * 2014-03-10 2018-03-22 한양대학교 산학협력단 세포 투과성 펩티드 및 이를 이용한 생물학적 활성 물질의 전달방법
WO2015176010A1 (fr) 2014-05-15 2015-11-19 The United States Of America, As Represented By The Secretary, Departmentof Health & Human Services Traitement ou prévention d'une maladie ou d'un trouble intestinal
ES2791953T3 (es) 2014-06-06 2020-11-06 Us Health Receptores de antígeno quimérico dirigidos a mesotelina y usos de los mismos
CN107074923B (zh) 2014-07-31 2021-08-03 Uab研究基金会 Apoe模拟肽及对清除血浆胆固醇的较高效力
US10925980B2 (en) 2014-08-04 2021-02-23 Case Western Reserve University Molecular probes and methods of use
US10124073B2 (en) 2014-08-04 2018-11-13 Case Western Reserve University Targeting peptides and methods of use
CA2957938A1 (fr) 2014-08-25 2016-03-03 GeneWeave Biosciences, Inc. Particules de transduction non replicatives et systemes rapporteurs les utilisant
US10385380B2 (en) 2014-10-02 2019-08-20 The Regents Of The University Of California Personalized protease assay to measure protease activity in neoplasms
KR101693431B1 (ko) 2014-11-18 2017-01-06 울산대학교 산학협력단 위암 표적용 펩타이드 및 이의 의학적 용도
SG10201900931XA (en) 2014-12-05 2019-02-27 Memorial Sloan Kettering Cancer Center Chimeric antigen receptors targeting b-cell maturation antigen and uses thereof
KR20230159637A (ko) 2014-12-05 2023-11-21 메모리얼 슬로안 케터링 캔서 센터 G-단백질 커플화 수용체를 표적화하는 항체 및 이의 사용 방법
HUE057777T2 (hu) 2014-12-05 2022-06-28 Memorial Sloan Kettering Cancer Center Kiméra antigén receptorok, amelyek G-fehérje-kapcsolt receptort céloznak meg, és a receptorok alkalmazásai
AU2015357533B2 (en) 2014-12-05 2021-10-07 Eureka Therapeutics, Inc. Antibodies targeting B-cell maturation antigen and methods of use
EP3227436A4 (fr) 2014-12-05 2018-06-20 Memorial Sloan Kettering Cancer Center Récepteurs antigéniques chimériques ciblant le récepteur fc-like 5 et leurs utilisations
WO2016122865A1 (fr) 2015-01-30 2016-08-04 Salk Institute For Biological Studies Compositions et procédés permettant de traiter un diabète lié à l'âge et des troubles associés
US11318163B2 (en) 2015-02-18 2022-05-03 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11497767B2 (en) 2015-02-18 2022-11-15 Enlivex Therapeutics R&D Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11596652B2 (en) 2015-02-18 2023-03-07 Enlivex Therapeutics R&D Ltd Early apoptotic cells for use in treating sepsis
US11000548B2 (en) 2015-02-18 2021-05-11 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
WO2016132366A1 (fr) 2015-02-18 2016-08-25 Enlivex Therapeutics Ltd. Association d'une immunothérapie et d'une thérapie de contrôle des cytokines pour le traitement du cancer
US11304976B2 (en) 2015-02-18 2022-04-19 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US10857181B2 (en) 2015-04-21 2020-12-08 Enlivex Therapeutics Ltd Therapeutic pooled blood apoptotic cell preparations and uses thereof
US10596259B2 (en) 2015-05-20 2020-03-24 The Regents Of The University Of California Tumor radiosensitization with monomethyl auristatin E (MMAE) and derivatives thereof
CA2986713A1 (fr) 2015-05-22 2016-12-01 Memorial Sloan-Kettering Cancer Center Anticorps semblables aux recepteurs de lymphocytes t specifiques pour un peptide prame
WO2016191263A1 (fr) 2015-05-22 2016-12-01 Trustees Of Dartmouth College Thérapie et nécessaire pour la prévention et le traitement de la fibrose kystique
US10509045B2 (en) 2015-05-29 2019-12-17 University Of Florida Research Foundation, Incorporated Methods for diagnosing Huntington's disease
GB201511546D0 (en) 2015-07-01 2015-08-12 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
PE20230321A1 (es) 2015-07-01 2023-02-22 Immatics Biotechnologies Gmbh Nuevos peptidos y nuevas combinaciones de peptidos para el uso en la inmunoterapia contra el cancer de ovario y otros tipos de cancer
WO2017023859A1 (fr) 2015-07-31 2017-02-09 Memorial Sloan-Kettering Cancer Center Protéines de liaison d'antigène ciblant cd56 et leurs utilisations
GB201515321D0 (en) 2015-08-28 2015-10-14 Immatics Biotechnologies Gmbh Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
DK3341482T3 (da) * 2015-08-28 2022-08-15 Curevac Ag Kunstige nukleinsyremolekyler
UA125817C2 (uk) 2015-08-28 2022-06-15 Імматікс Біотекнолоджіс Гмбх Пептид, придатний для лікування та/або діагностики раку
ES2887201T3 (es) * 2015-09-01 2021-12-22 Eisai R&D Man Co Ltd Variantes de empalme asociadas con mutantes neomórficos de SF3B1
CA2997551A1 (fr) 2015-09-04 2017-03-09 Memorial Sloan Kettering Cancer Center Compositions a base de cellules immunitaires et leurs procedes d'utilisation
US10858395B2 (en) * 2015-09-10 2020-12-08 Iucf-Hyu (Industry-University Cooperation Foundation Hanyang University) Skin-penetrating peptide and method for using same
NZ743124A (en) 2015-12-04 2022-11-25 Memorial Sloan Kettering Cancer Center Antibodies targeting fc receptor-like 5 and methods of use
WO2017100428A1 (fr) 2015-12-09 2017-06-15 Memorial Sloan Kettering Cancer Center Compositions à base de cellules immunitaires et leurs méthodes d'utilisation
US11505599B2 (en) 2016-01-14 2022-11-22 Memorial Sloan-Kettering Cancer Center T cell receptor-like antibodies specific for Foxp3-derived peptides
US11730761B2 (en) 2016-02-18 2023-08-22 Enlivex Therapeutics Rdo Ltd Combination immune therapy and cytokine control therapy for cancer treatment
GB201604490D0 (en) 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Peptides combination of peptides for use in immunotherapy against cancers
US10940161B2 (en) 2016-04-04 2021-03-09 University Of Florida Research Foundation, Incorporated Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation
ES2933961T3 (es) 2016-04-15 2023-02-15 Memorial Sloan Kettering Cancer Center Células T transgénicas y composiciones de células T de receptor de antígeno quimérico y métodos relacionados
US20170360881A1 (en) * 2016-06-17 2017-12-21 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
US20180052169A1 (en) * 2016-08-22 2018-02-22 The Board Of Regents Of The University Of Texas System Tsp1 as a marker for cancer
CA3034691A1 (fr) 2016-08-30 2018-03-08 Memorial Sloan Kettering Cancer Center Compositions de cellules immunitaires et procedes d'utilisation pour le traitement d'infections virales et d'autres infections
AU2017342555A1 (en) 2016-10-14 2019-05-30 Children's Medical Center Corporation Compositions and methods for treating diseases and disorders of the central nervous system
BR112019009446A2 (pt) 2016-11-09 2019-07-30 Intrexon Corp construtos de expressão da frataxina
WO2018089909A1 (fr) * 2016-11-13 2018-05-17 Imagine Pharma Compositions et méthodes pour le traitement du diabète, de l'hypertension et de l'hypercholestérolémie
GB201621737D0 (en) * 2016-12-20 2017-02-01 Aberystwyth Univ Compositions and methods of treatment
WO2018127916A1 (fr) 2017-01-05 2018-07-12 Kahr Medical Ltd. Protéine de fusion pd1-cd70 et ses procédés d'utilisation
DK3565579T3 (da) 2017-01-05 2023-09-04 Kahr Medical Ltd Pd1-41bbl-fusionsprotein og fremgangsmåder til anvendelse deraf
US11299530B2 (en) 2017-01-05 2022-04-12 Kahr Medical Ltd. SIRP alpha-CD70 fusion protein and methods of use thereof
HRP20220230T1 (hr) 2017-01-05 2022-04-29 Kahr Medical Ltd. Sirp1 alfa-41bbl fuzijski protein i metoda njegove upotrebe
WO2018136435A1 (fr) 2017-01-17 2018-07-26 Children's Medical Center Corporation Compositions et procédés de traitement de maladies et de troubles du stockage lysosomial
CA3050109A1 (fr) 2017-01-18 2018-07-26 Ichan School Of Medicine At Mount Sinai Neoantigenes et leurs utilisations dans le traitement du cancer
US11260101B2 (en) * 2017-02-28 2022-03-01 Jinan University Repair peptide for use in promoting post-traumatic tissue repair and regeneration, and application thereof
WO2018165228A1 (fr) 2017-03-08 2018-09-13 Memorial Sloan Kettering Cancer Center Compositions à base de cellules immunitaires et leurs procédés d'utilisation
KR102667951B1 (ko) 2017-04-03 2024-05-22 에프. 호프만-라 로슈 아게 Steap-1에 결합하는 항체
CA3060250A1 (fr) 2017-04-17 2018-10-25 University Of Florida Research Foundation, Incorporated Regulation de la traduction de la proteine ran par les voies pkr et eif2a-p
CN110536694A (zh) 2017-04-20 2019-12-03 Atyr 医药公司 用于治疗肺部炎症的组合物和方法
TW202333779A (zh) 2017-05-08 2023-09-01 美商磨石生物公司 阿爾法病毒新抗原載體
JP7315475B2 (ja) * 2017-05-19 2023-07-26 エンコーデッド セラピューティクス， インコーポレイテッド 高活性制御エレメント
CA3076214A1 (fr) 2017-09-26 2019-04-04 University Of Florida Research Foundation, Incorporated Utilisation de metformine et d'analogues de celle-ci pour reduire les taux de proteine ran lors d'un traitement de troubles neurologiques
EP3687629A4 (fr) 2017-09-27 2021-10-06 University of Georgia Research Foundation Traitement et détection d'une infection et d'une maladie associées à différents pathogènes fongiques
EP3710020A4 (fr) 2017-11-14 2021-06-23 Memorial Sloan-Kettering Cancer Center Cellules immunoréactives sécrétant l'il-36 et utilisations associées
US11008602B2 (en) 2017-12-20 2021-05-18 Roche Molecular Systems, Inc. Non-replicative transduction particles and transduction particle-based reporter systems
EP3732195A4 (fr) 2017-12-28 2022-02-09 Chugai Seiyaku Kabushiki Kaisha Agent thérapeutique induisant une cytotoxicité
WO2019133969A2 (fr) 2017-12-29 2019-07-04 Memorial Sloan-Kettering Cancer Center Récepteurs antigéniques chimériques améliorés et leurs utilisations
SG11202006400UA (en) 2018-01-04 2020-08-28 Iconic Therapeutics Inc Anti-tissue factor antibodies, antibody-drug conjugates, and related methods
CN116041516A (zh) 2018-02-01 2023-05-02 信达生物制药(苏州)有限公司 全人源的抗b细胞成熟抗原(bcma)单链抗体及其应用
WO2019157454A1 (fr) 2018-02-11 2019-08-15 Memorial Sloan-Kettering Cancer Center Récepteurs de lymphocytes t non restreints par hla et leurs utilisations
EP3752601A4 (fr) 2018-02-15 2022-03-23 Memorial Sloan-Kettering Cancer Center Compositions d'agent ciblant le foxp3 et méthodes d'utilisation pour une thérapie cellulaire adoptive
CN112055598A (zh) * 2018-03-02 2020-12-08 迪克纳制药公司 用于抑制gys2表达的组合物和方法
KR20210044220A (ko) 2018-07-11 2021-04-22 카 메디컬 리미티드 SIRPalpha-4-1BBL 변이체 융합 단백질 및 이의 사용 방법
AU2019380320A1 (en) 2018-11-16 2021-06-03 Eureka Therapeutics, Inc. Antibodies to Mucin-16 and methods of use thereof
JP2022527297A (ja) 2019-03-27 2022-06-01 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア Ｔｎ－ＭＵＣ１キメラ抗原受容体（ＣＡＲ）Ｔ細胞療法
CN110256574B (zh) * 2019-05-21 2020-12-04 山东大学 融合多肽及在制备抗抑郁、神经退行性疾病药物中的应用
BR122024002387A2 (pt) 2019-05-30 2024-03-12 Gritstone Bio, Inc. Vetores de adenovírus, composição farmacêutica, sequência de nucleotídeo isolada, célula isolada, vetor, kit, usos de um vetor, método para fabricar o vetor, métodos para produzir um vírus e vetor viral
WO2021072005A1 (fr) * 2019-10-08 2021-04-15 North Carolina State University Peptides de purification d'immunoglobuline et leur utilisation
MX2022004962A (es) 2019-10-28 2022-08-16 Noile Immune Biotech Inc Fármaco para el tratamiento del cáncer, combinación de fármacos, composición de fármacos, célula de respuesta inmune, vehículo de administración de ácidos nucleicos y producto.
CN115151274A (zh) * 2019-11-05 2022-10-04 得克萨斯州大学系统董事会 Hla限制性hormad1 t细胞受体及其用途
WO2021158818A1 (fr) * 2020-02-05 2021-08-12 Synthetic Genomics, Inc. Séquences régulatrices pour l'expression de transgènes
JP2023519346A (ja) 2020-03-27 2023-05-10 メンドゥス・ベスローテン・フェンノートシャップ 養子細胞療法の有効性を増強するための白血病由来の改変細胞のエクスビボ（ｅｘ ｖｉｖｏ）使用
AU2021244937A1 (en) 2020-03-27 2022-11-03 Mendus B.V. In vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
SG11202105302PA (en) 2020-03-31 2021-11-29 Chugai Pharmaceutical Co Ltd Dll3-targeting multispecific antigen-binding molecules and uses thereof
JP2023532347A (ja) 2020-06-29 2023-07-27 セル メディカ，インコーポレイテッド キメラ抗原受容体の緊張性シグナル伝達を減少させる方法および組成物
WO2022032196A2 (fr) 2020-08-06 2022-02-10 Gritstone Bio, Inc. Cassettes de vaccin à plusieurs épitopes
EP4192875A1 (fr) 2020-08-10 2023-06-14 Precision BioSciences, Inc. Anticorps et fragments spécifiques de l'antigène de maturation des lymphocytes b et leurs utilisations
EP4222267A1 (fr) 2020-09-30 2023-08-09 Vor Biopharma Inc. Systèmes d'expression de récepteur d'antigène chimérique
AU2021375493A1 (en) 2020-11-05 2023-06-29 Mendus B.V. Use of tumor-independent antigens in immunotherapies
EP4243858A1 (fr) 2020-11-13 2023-09-20 Vor Biopharma Inc. Méthodes et compositions se rapportant à des cellules génétiquement modifiées exprimant des récepteurs d'antigènes chimériques
EP4304632A2 (fr) 2021-03-11 2024-01-17 Mnemo Therapeutics Peptides néo-antigéniques de tumeur
JP2024511941A (ja) * 2021-03-11 2024-03-18 テンザ、インク． 酵母における異種タンパク質の分泌を指示するための合成シグナルペプチド
EP4304635A1 (fr) 2021-03-11 2024-01-17 Mnemo Therapeutics Peptides néo-antigéniques tumoraux et leurs utilisations
AU2022232196A1 (en) 2021-03-11 2023-09-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Transmembrane neoantigenic peptides
EP4323013A2 (fr) * 2021-04-13 2024-02-21 Capsida, Inc. Compositions de vaa sélectionnées ayant un enrichissement cérébral préféré
JP2024514933A (ja) 2021-04-23 2024-04-03 ベイラー カレッジ オブ メディスン Ｍｈｃクラスｉ及びｉｉ発現の下方調節のための人工マイクロｒｎａ埋込ｓｈｒｎａを発現するｃａｒ ｎｋｔ
WO2022235832A1 (fr) 2021-05-06 2022-11-10 Ludwig Institute For Cancer Research Ltd Compositions et méthodes d'immunothérapie
WO2022238386A1 (fr) 2021-05-10 2022-11-17 Institut Curie Procédés de traitement du cancer, de maladies inflammatoires et de maladies auto-immunes
WO2022248602A1 (fr) 2021-05-25 2022-12-01 Institut Curie Cellules myéloïdes surexprimant bcl2
WO2023288203A2 (fr) 2021-07-12 2023-01-19 Ludwig Institute For Cancer Research Ltd Récepteurs de lymphocytes t spécifiques pour des antigènes associés aux tumeurs et leurs procédés d'utilisation
WO2023022788A1 (fr) * 2021-08-18 2023-02-23 The Regents Of The University Of California Procédés et compositions servant à déterminer le risque d'un trouble du spectre autistique
WO2023064872A1 (fr) 2021-10-14 2023-04-20 Precision Biosciences, Inc. Associations de lymphocytes t car anti-bcma et d'inhibiteurs de gamma secrétase
WO2023192626A1 (fr) * 2022-04-01 2023-10-05 The Regents Of The University Of California Méthodes et compositions pour traiter des gliomes
US20240002800A1 (en) 2022-05-16 2024-01-04 Mendus B.V. Use of leukemia-derived cells for enhancing natural killer (nk) cell therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287801B1 (en) * 1996-07-22 2001-09-11 Smithkline Beecham Corporation Nucleic acids encoding the G-protein coupled receptor HNFDS78
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
US20030235883A1 (en) * 2000-03-31 2003-12-25 Tang Y. Tom Novel nucleic acids and polypeptides
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides

Also Published As

Publication number Publication date
US20020146757A1 (en) 2002-10-10
US6436703B1 (en) 2002-08-20
WO2001075067A8 (fr) 2004-10-14
US20030087370A1 (en) 2003-05-08
US6610536B2 (en) 2003-08-26
WO2001075067A2 (fr) 2001-10-11
US20050196754A1 (en) 2005-09-08
WO2001075067A3 (fr) 2002-04-04
US20020061567A1 (en) 2002-05-23
WO2001075067A9 (fr) 2002-10-31
US20030096279A1 (en) 2003-05-22
US20030092112A1 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001234944A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001296235A1 (en) Novel nucleic acids and polypeptides
AU2001263006A1 (en) Novel nucleic acids and polypeptides
AU2002246502A1 (en) Nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
AU2002366951A1 (en) Novel nucleic acids and polypeptides
AU2002326877A1 (en) Novel nucleic acids and polypeptides
AU2002314709A1 (en) Novel nucleic acids and polypeptides
AU2002343417A1 (en) Novel nucleic acids and polypeptides
AU2001241511A1 (en) Novel nucleic acids and polypeptides
AU2001292561A1 (en) Nucleic acids and polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
WO2002016439A8 (fr) Nouveaux acides nucleiques et polypeptides
EP1341803A4 (fr) Nouveaux acides nucleiques et polypeptides
AU3511100A (en) Novel nucleic acids and polypeptides
AU2002250419A1 (en) Novel nucleic acids and polypeptides
AU2001263005A1 (en) Novel nucleic acids and polypeptides
AU2001252926A1 (en) Novel nucleic acids and polypeptides
EP1268762A4 (fr) Nouveaux acides nucleiques et polypeptides